U.S. flag

An official website of the United States government

NM_024006.6(VKORC1):c.174-136C>T AND Vitamin K-Dependent Clotting Factors

Germline classification:
Benign (1 submission)
Last evaluated:
Jun 14, 2016
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000291997.13

Allele description [Variation Report for NM_024006.6(VKORC1):c.174-136C>T]

NM_024006.6(VKORC1):c.174-136C>T

Gene:
VKORC1:vitamin K epoxide reductase complex subunit 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16p11.2
Genomic location:
Preferred name:
NM_024006.6(VKORC1):c.174-136C>T
HGVS:
  • NC_000016.10:g.31093557G>A
  • NG_011564.1:g.6399C>T
  • NM_001311311.2:c.174-136C>T
  • NM_024006.6:c.174-136C>TMANE SELECT
  • NM_206824.3:c.173+1000C>T
  • LRG_582t1:c.174-136C>T
  • LRG_582:g.6399C>T
  • NC_000016.9:g.31104878G>A
  • NM_024006.4:c.174-136C>T
Links:
PharmGKB: 1183704228; PharmGKB: 1183704228PA450921; PharmGKB: 1183704228PA452632; PharmGKB: 655385392; PharmGKB: 655385392PA451906; PharmGKB Clinical Annotation: 1183704228; PharmGKB Clinical Annotation: 655385392; OMIM: 608547.0008; dbSNP: rs9934438
NCBI 1000 Genomes Browser:
rs9934438
Molecular consequence:
  • NM_001311311.2:c.174-136C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_024006.6:c.174-136C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_206824.3:c.173+1000C>T - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Vitamin K-Dependent Clotting Factors
Identifiers:
MedGen: CN239236

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000396620Illumina Laboratory Services, Illumina
criteria provided, single submitter

(ICSL Variant Classification 20161018)
Benign
(Jun 14, 2016)
germlineclinical testing

ICSL_Variant_Classification_20161018.pdf

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Illumina Laboratory Services, Illumina, SCV000396620.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jul 7, 2024